文献速递肿瘤 PET/CT

18F-FDG PET/CT在食管恶性血管球瘤中的临床意义

Clinical Implications of 18F-FDG PET/CT in Malignant Glomus Tumors of the Esophagus.
PubMed 文献 · Clin Nucl Med · 2020-01-01

本文报告一例45岁男性严重吞咽困难患者,诊断为食管恶性血管球瘤。18F-FDG PET/CT在初始分期、复发检测及多种全身治疗的反应评估中均发挥了决定性作用,提供了此前未知的准确性。

要点

  • 食管恶性血管球瘤罕见且侵袭性强,18F-FDG PET/CT在初始分期中可评估局部肿瘤范围。
  • 术后一年半,18F-FDG PET/CT有助于检测复发。
  • 18F-FDG PET/CT还用于多种全身治疗的反应评估。

核心结论

  • 18F-FDG PET/CT在食管恶性血管球瘤患者管理的多个阶段发挥了决定性作用,提供了此前未知的准确性。

研究设计与样本

  • 本文报告一例45岁男性严重吞咽困难患者,诊断为食管恶性血管球瘤。

主要发现

  • 18F-FDG PET/CT首先在术前用于初始分期评估局部肿瘤范围。
  • 一年半后,18F-FDG PET/CT帮助检测复发。
  • 最后,18F-FDG PET/CT用于多种全身治疗的反应评估。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The majority of glomus tumors are localized to cutaneous sites and are benign. However, extracutaneous malignant glomus tumors have been reported and are aggressive. Here, we report a case of a 45-year-old man who presented severe dysphagia, diagnosed with malignant glomus tumor of the esophagus. F-FDG PET/CT played a decisive role in several phases of the patient management offering previously unknown accuracy. It was first performed in the initial staging of local tumor extent before surgery. A year and a half after, F-FDG PET/CT helped to detect recurrence and, finally, was performed for response evaluation of several systemic therapies.

来源:Clin Nucl Med,查看原文。版权归原作者所有。

引用

  1. Seban RD, Bozec L, Champion L, et al. Clinical Implications of 18F-FDG PET/CT in Malignant Glomus Tumors of the Esophagus. Clin Nucl Med. 2020. PMID: 32332312. doi:10.1097/RLU.0000000000003029

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。